David Shaw’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-242,448
| Closed | -$4.23M | – | 4674 |
|
|
2020
Q4 | $4.23M | Sell |
242,448
-7,855
| -3% | -$110K | ﹤0.01% | 1998 |
|
|
2020
Q3 | $2.93M | Buy |
250,303
+20,231
| +9% | +$268K | ﹤0.01% | 2095 |
|
|
2020
Q2 | $2.99M | Buy |
230,072
+23,159
| +11% | +$278K | ﹤0.01% | 2084 |
|
|
2020
Q1 | $1.92M | Buy |
206,913
+15,758
| +8% | +$220K | ﹤0.01% | 2200 |
|
|
2019
Q4 | $3.17M | Buy |
191,155
+18,774
| +11% | +$304K | ﹤0.01% | 2108 |
|
|
2019
Q3 | $2.87M | Sell |
172,381
-10,624
| -6% | -$147K | ﹤0.01% | 2088 |
|
|
2019
Q2 | $2.52M | Sell |
183,005
-25,362
| -12% | -$388K | ﹤0.01% | 2077 |
|
|
2019
Q1 | $3.59M | Buy |
208,367
+54,147
| +35% | +$857K | ﹤0.01% | 1771 |
|
|
2018
Q4 | $1.97M | Sell |
154,220
-8,556
| -5% | -$130K | ﹤0.01% | 2162 |
|
|
2018
Q3 | $2.64M | Buy |
162,776
+42,718
| +36% | +$611K | ﹤0.01% | 2008 |
|
|
2018
Q2 | $1.55M | Buy |
120,058
+95,222
| +383% | +$1.29M | ﹤0.01% | 2415 |
|
|
2018
Q1 | $309K | Sell |
24,836
-21,800
| -47% | -$265K | ﹤0.01% | 3137 |
|
|
2017
Q4 | $652K | Sell |
46,636
-11,005
| -19% | -$161K | ﹤0.01% | 2824 |
|
|
2017
Q3 | $968K | Sell |
57,641
-15,030
| -21% | -$245K | ﹤0.01% | 2508 |
|
|
2017
Q2 | $1.22M | Buy |
72,671
+14,754
| +25% | +$220K | ﹤0.01% | 2288 |
|
|
2017
Q1 | $897K | Buy |
57,917
+21,902
| +61% | +$313K | ﹤0.01% | 2365 |
|
|
2016
Q4 | $538K | Buy |
36,015
+8,313
| +30% | +$117K | ﹤0.01% | 2805 |
|
|
2016
Q3 | $348K | Sell |
27,702
-3,212
| -10% | -$32.2K | ﹤0.01% | 2982 |
|
|
2016
Q2 | $278K | Sell |
30,914
-3,032
| -9% | -$29.7K | ﹤0.01% | 3061 |
|
|
2016
Q1 | $336K | Buy |
33,946
+1,423
| +4% | +$14.6K | ﹤0.01% | 2970 |
|
|
2015
Q4 | $374K | Buy |
32,523
+15,483
| +91% | +$192K | ﹤0.01% | 3257 |
|
|
2015
Q3 | $230K | Sell |
17,040
-198
| -1% | -$2.68K | ﹤0.01% | 3450 |
|
|
2015
Q2 | $239K | Buy |
17,238
+2,160
| +14% | +$29.2K | ﹤0.01% | 3509 |
|
|
2015
Q1 | $212K | Buy |
+15,078
| New | +$205K | ﹤0.01% | 3434 |
|
David Shaw's OXFD Position: Q1 2021 in Review
David Shaw sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 242,448 shares — an estimated $4.23M sold.
David Shaw first reported a position in OXFD in Q1 2015 and held it in 24 quarters. The position peaked at $4.23M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.
- David Shaw reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
- David Shaw sold 242,448 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $4.23M.
- David Shaw first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2015 and held it in 24 quarters.
- David Shaw's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.23M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.